Keyphrases
Active Sites
25%
Aldehydes
25%
Alkylation
31%
Amides
49%
Amino
36%
Amino Acids
27%
Angiotensin-converting Enzyme Inhibitor (ACEi)
26%
Annual Review
25%
Annulation
25%
ATP Citrate Lyase
42%
Aurodox
25%
Benzamide
51%
Bradykinin
36%
Bradykinin B2 Receptor Antagonist
33%
Chemical Library
47%
Chiral Ligands
25%
Citric Acid
25%
Combinatorial Library
71%
Comprehensive Survey
33%
Converting Enzyme
42%
Dimethyl
56%
Dopamine
25%
Gyrase B Inhibitor
25%
Hydroxylase
25%
Inducible Nitric Oxide Synthase
25%
Interleukin-1β
58%
Irreversible Inhibitor
25%
Ketones
28%
Library Synthesis
36%
Linker
29%
Methyl
49%
Nonapeptides
52%
Novel Class
47%
Opioid Antagonist
100%
Opioid Receptors
54%
P-hydroxyphenyl
38%
Phenyl
25%
Piperidine
65%
Polymer Support
28%
Potent Inhibitor
25%
Resin
46%
Scavenger
25%
Solid-phase Reagents
25%
Solid-phase Synthesis
33%
Sterols
29%
Structure-activity Relationship
70%
Sulfamoyl
28%
Synthon
46%
Total Synthesis
37%
Tyrosine
35%
Pharmacology, Toxicology and Pharmaceutical Science
Acetone
16%
Adenosine Triphosphate Citrate Synthase
33%
Amino Acid
30%
Analgesic Agent
27%
Aspartic Acid
21%
Benzamide
22%
Benzamide Derivative
28%
Bradykinin
31%
Bradykinin Antagonist
18%
Bradykinin B2 Receptor Antagonist
33%
Calcium Ion
16%
Calpain 1
16%
Candida Albicans
19%
Cannabinoid
16%
Cannabinoid 2 Receptor
19%
Cannabinoid 2 Receptor Agonist
37%
Carboxamide
77%
Combinatorial Library
28%
Cysteine Proteinase
16%
Delta Opiate Receptor Agonist
16%
Dipeptidyl Carboxypeptidase
29%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Disorders of Mitochondrial Functions
16%
Dopamine Beta Monooxygenase
16%
Drug Development
21%
Drug Discovery
16%
Hypolipemia
25%
IC50
15%
Inflammatory Disease
16%
Interleukin 1
25%
Lactam
25%
Lead Compound
15%
Methyltransferase
16%
Mu Opiate Receptor Antagonist
16%
Narcotic Antagonist
57%
Opiate Agonist
55%
Opiate Receptor
60%
Pharmaceutical Chemistry
27%
Pharmacokinetics
24%
Piperazine Derivative
16%
Piperidine
50%
Piperidine Derivative
22%
Plasmepsin II
16%
Prodrug
16%
Proteinase
23%
Receptor
78%
Receptor Agonist
16%
Statine
16%
Sterol
19%
Structure Activity Relationship
85%